Presentation and Outcomes with Clinically Apparent Interferon Beta Hepatotoxicity

Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop

(2010) Robert J. Fontana et al.   HEPATOLOGY

Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study

(2010) Adrian Reuben et al.   HEPATOLOGY

The changing demographic pattern of multiple sclerosis epidemiology

(2010) Nils Koch-Henriksen et al.   LANCET NEUROLOGY

High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study

(2010) S Chan et al.   Multiple Sclerosis Journal

Acetaminophen Modulates the Transcriptional Response to Recombinant Interferon-β

(2010) Aaron Farnsworth et al.   PLoS One

Drug-Induced Liver Injury Network (DILIN) Prospective Study

(2009) Robert J. Fontana et al.   DRUG SAFETY

Asthma in men and women: Treatment adherence, anxiety, and quality of sleep

(2009) Rosita Sundberg et al.   RESPIRATORY MEDICINE

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

(2008) Naga Chalasani et al.   GASTROENTEROLOGY

Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury

(2008) James Rochon et al.   HEPATOLOGY

Temporal trends in the incidence of multiple sclerosis: A systematic review

(2008) A. Alonso et al.   NEUROLOGY

Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination?

(2008) Giada Pietrosi et al.   TRANSPLANT INTERNATIONAL